Skip to content
value.today

Vaxinnate Corp.

Total raised
$24 M
3 rounds on record
Latest round
$3 M
Sep 2015
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vaxinnate Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2015$3 MNo. 3$2 to $10 million

Vaxinnate Corp.: Raise no. 3, Sep 2015

Investors in this round

14 investors had bought by the notice of Sep 28, 2015: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kathleen A. McGowan · Executive Officer
  • Lynda A. Tussey · Executive Officer
  • Wayne Pisano · Executive Officer, Director
  • Augustine O. Lawlor · Director
  • David O. Williams · Director
  • Philippe O. Chambon · Director
  • Sam O. Wu · Director
  • Thomas A. Monath · Director
  • Timothy O. Shannon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kathleen A. McGowan, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 28, 2015. Read the notice at the SEC.

equitySEC
Sep 2014$6 MNo. 2$2 to $10 million

Vaxinnate Corp.: Raise no. 2, Sep 2014

Investors in this round

9 investors had bought by the notice of Oct 2, 2014: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kathleen A. McGowan · Executive Officer
  • Wayne Pisano · Executive Officer, Director
  • Augustine O. Lawlor · Director
  • David O. Williams · Director
  • Phillippe O. Chambon · Director
  • Sam O. Wu · Director
  • Seth O. Rudnick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kathleen A. McGowan, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 2, 2014. Read the notice at the SEC.

equitySEC
May 2009$15 MNo. 1$10 to $50 million

Vaxinnate Corp.: Raise no. 1, May 2009

Investors in this round

12 investors had bought by the notice of May 19, 2009: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $31 M offered; $16 M still to sell
Smallest investment taken
$3,558
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in De

People named in the notice

  • Alan R. Shaw · Director, Executive Officer · President and Chief Executive Officer
  • Andrew T. Drechsler · Executive Officer · Chief Financial Officer and Secretary
  • Augustine Lawlor · Director
  • David Williams · Director
  • Franklin H. Top, Jr. · Director
  • Gregory Weinhoff · Director
  • Julie Eskay-Eagle · Director
  • Philippe Chambon · Director
  • Seth F. Berkley · Director
  • Seth Rudnick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew T. Drechsler, Chief Financial Officer and Secretary. Source: SEC Form D, newest notice filed May 19, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vaxinnate Corp. chose not to state its revenue in its newest notice of a funding round (Sep 2015).

    SEC Form D · Sep 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2015

That is all the official record says: Vaxinnate Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vaxinnate Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 14 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vaxinnate Corp.
NameRoleNamed in
Kathleen A. McGowanExecutive officerSep 2015
Lynda A. TusseyExecutive officerSep 2015
Wayne PisanoExecutive officerSep 2015
Alan R. ShawPresident and Chief Executive OfficerMay 2009
Andrew T. DrechslerChief Financial Officer and SecretaryMay 2009
Augustine O. LawlorDirectorSep 2015
David O. WilliamsDirectorSep 2015
Philippe O. ChambonDirectorSep 2015
Sam O. WuDirectorSep 2015
Thomas A. MonathDirectorSep 2015
Timothy O. ShannonDirectorSep 2015
Wayne PisanoDirectorSep 2015
Phillippe O. ChambonDirectorOct 2014
Seth O. RudnickDirectorOct 2014
Alan R. ShawPresident and Chief Executive OfficerMay 2009
Augustine LawlorDirectorMay 2009
David WilliamsDirectorMay 2009
Franklin H. Top, Jr.DirectorMay 2009
Gregory WeinhoffDirectorMay 2009
Julie Eskay-EagleDirectorMay 2009
Philippe ChambonDirectorMay 2009
Seth F. BerkleyDirectorMay 2009
Seth RudnickDirectorMay 2009